← Browse by Condition
Medical Condition

melanoma stage iiib iv

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT06624644 Phase 2, Phase 3
Recruiting

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Enrollment
135 pts
Location
United States
Sponsor
Linnaeus Therapeutics, Inc.
View Trial →